Strides Pharma Science Ltd.
| BSE: 532531 | Sector: Health care |
| NSE: STAR | ISIN Code: INE939A01011 |
| BSE 12:44 | 02 Aug | 770.40 |
0.25 (0.03%) |
OPEN
780.00 |
HIGH
780.00 |
LOW
758.90 |
| NSE 12:34 | 02 Aug | 768.70 |
-1.80 (-0.23%) |
OPEN
776.00 |
HIGH
776.00 |
LOW
758.60 |
| OPEN | 780.00 |
| PREVIOUS CLOSE | 770.15 |
| VOLUME | 8580 |
| 52-Week high | 1000.00 |
| 52-Week low | 408.30 |
| P/E | 88.35 |
| Mkt Cap.(Rs cr) | 6,912 |
| Buy Price | 770.45 |
| Buy Qty | 4.00 |
| Sell Price | 770.75 |
| Sell Qty | 12.00 |
Strides Pharma Science Ltd. (STAR) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 777.60 | 3.60 | 0.47 | 3211.14 |
| Cipla | 921.95 | 1.65 | 0.18 | 2318.17 |
| Dr Reddy's Labs | 4747.40 | 34.70 | 0.74 | 2186.40 |
| Aurobindo Pharma | 917.15 | 0.30 | 0.03 | 1872.74 |
| Alkem Lab | 3471.60 | 17.05 | 0.49 | 1685.08 |
| Cadila Health. | 593.30 | 7.35 | 1.25 | 1476.20 |
| Divi's Lab. | 4935.90 | 31.25 | 0.64 | 1372.71 |
| Glenmark Pharma. | 609.15 | 1.55 | 0.26 | 1354.55 |
| Lupin | 1123.00 | 15.85 | 1.43 | 1258.62 |
| Alembic Pharma | 783.65 | -4.00 | -0.51 | 1175.39 |
| Torrent Pharma. | 3078.20 | 8.50 | 0.28 | 1137.85 |
| Laurus Labs | 658.05 | 17.40 | 2.72 | 956.11 |
| Gland Pharma | 4003.00 | 54.55 | 1.38 | 772.86 |
| Abbott India | 19876.00 | 789.85 | 4.14 | 690.69 |
| Ajanta Pharma | 2281.25 | -7.85 | -0.34 | 675.64 |
| Ipca Labs. | 2091.75 | -10.10 | -0.48 | 652.46 |
| Wockhardt | 530.65 | 1.15 | 0.22 | 593.29 |
| Granules India | 387.70 | 8.35 | 2.20 | 552.78 |
| Pfizer | 5953.15 | 82.15 | 1.40 | 497.61 |
| Sanofi India | 8581.20 | 213.30 | 2.55 | 477.60 |
Quick Links for Strides Pharma Science:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
